A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy
Emily J. Lelliott(The University of Melbourne), Karen E. Sheppard(The University of Melbourne)
Cited by 29
Related Papers
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study
|Cancer Discovery|2019|201
NKG7 Enhances CD8+ T Cell Synapse Efficiency to Limit Inflammation
|Frontiers in Immunology|2022|33